Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.

Published in:

2018

By:

• van Linge, A.;
• van Os, R.;
• Hoekstra, N.;
• Heijmen, B.;
• Stienstra, L.;
• Dallenga, A.;
• Wolbers, J.;
• Mendez Romero, A.

Publication type:

journal article